@prefix nkg: . @prefix nt: . @prefix orcid: . @prefix bl: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "Only a few pharmacological treatments are available for treating alcohol use disorders (AUDs). Disulfiram, naltrexone and acamprosate are Food and Drug Administration (FDA)-approved and nalmefene is EMA-approved in European Union. Off-label medications, such as baclofen, gabapentin, ondansetron and topiramate are medications commonly prescribed for the treatment of AUD."; bl:has_population_context sub:context; bl:provided_by ; bl:publications ; bl:relation nkg:OffLabelIndication . sub:context a bl:Cohort; rdfs:label "Adults" . a bl:Drug . } sub:provenance { sub:assertion prov:generatedAtTime "2021-08-24T17:08:55.231206"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"; npx:hasSignature "Z/N4Ib0kttj6oanLhGlq5jV9Th3HqNqxnUVJwL8v3jxhEpmyK1LMyOnOpBZWLK1Cguhm9i9o3rTjBJUmA+8oLaXVkVBuCwmRikBFo/xylDwQ6lKaEgNaBuePNkWAIQHawoMhGeZcgMH2YWbKg37WycS0XvCoLnlroyajicKekMY="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-08-24T17:08:55.231206"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-7641-6446; nt:wasCreatedFromTemplate . }